Fiji vs Republic of Korea: Previously treated cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
Republic of Korea
100.0%
in 2024
Fiji rank
1st
Republic of Korea rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Fiji
- Republic of Korea
How they compare
Fiji currently reports 100.0% against 100.0% in Republic of Korea, a difference of 0.0%.
The two have swapped places 4 times across 13 shared years of data; in 2011 it was Republic of Korea ahead.
Fiji ranks 1st and Republic of Korea ranks 1st of 180 countries.
Republic of Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Fiji | Republic of Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.1% | 55.5% | 0.4% | Republic of Korea |
| 2020s | 81.8% | 92.0% | 10.2% | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Fiji or Republic of Korea?
- Fiji, at 100.0% against 100.0% in Republic of Korea as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Fiji and Republic of Korea?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Republic of Korea?
- 13 years are reported by both, from 2011 to 2024.
- How do Fiji and Republic of Korea rank globally for previously treated cases tested for rr-/mdr-tb?
- Fiji ranks 1st and Republic of Korea ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.